PT Kedoya Adyaraya Tbk (RSGK.JK)
IDR 980.0
(0.0%)
IDR 980.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 77.63 Billion IDR | -0.67% |
| 2022 | 78.15 Billion IDR | -25.12% |
| 2021 | 104.36 Billion IDR | -60.62% |
| 2020 | 265 Billion IDR | 4.78% |
| 2019 | 252.91 Billion IDR | -33.52% |
| 2018 | 380.46 Billion IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 98.2 Billion IDR | 26.5% |
| 2024 Q2 | 99.02 Billion IDR | 0.84% |
| 2024 Q3 | 93.32 Billion IDR | -5.76% |
| 2023 Q1 | 92.59 Billion IDR | 18.48% |
| 2023 Q4 | 77.63 Billion IDR | 9.64% |
| 2023 Q3 | 70.8 Billion IDR | -52.7% |
| 2023 FY | 77.63 Billion IDR | -0.67% |
| 2023 Q2 | 149.7 Billion IDR | 61.67% |
| 2022 Q2 | 163.27 Billion IDR | 60.09% |
| 2022 FY | 78.15 Billion IDR | -25.12% |
| 2022 Q4 | 78.15 Billion IDR | 6.45% |
| 2022 Q3 | 73.41 Billion IDR | -55.03% |
| 2022 Q1 | 101.98 Billion IDR | -2.28% |
| 2021 Q3 | 209.1 Billion IDR | -1.1% |
| 2021 FY | 104.36 Billion IDR | -60.62% |
| 2021 Q1 | - IDR | -100.0% |
| 2021 Q2 | 211.43 Billion IDR | 0.0% |
| 2021 Q4 | 104.36 Billion IDR | -50.09% |
| 2020 FY | 265 Billion IDR | 4.78% |
| 2020 Q4 | 265 Billion IDR | 0.0% |
| 2019 FY | 252.91 Billion IDR | -33.52% |
| 2018 FY | 380.46 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PT Bundamedik Tbk | 1283.12 Billion IDR | 93.95% |
| PT Metro Healthcare Indonesia Tbk | 1039.28 Billion IDR | 92.53% |
| PT Medikaloka Hermina Tbk | 3604.32 Billion IDR | 97.846% |
| PT Mitra Keluarga Karyasehat Tbk | 741.05 Billion IDR | 89.524% |
| PT Murni Sadar Tbk | 708.74 Billion IDR | 89.046% |
| PT Famon Awal Bros Sedaya Tbk | 1769.45 Billion IDR | 95.613% |
| PT Royal Prima Tbk | 49.68 Billion IDR | -56.251% |
| PT Sarana Meditama Metropolitan Tbk | 1381.15 Billion IDR | 94.379% |
| PT Siloam International Hospitals Tbk | 2934.42 Billion IDR | 97.354% |
| PT Sejahteraraya Anugrahjaya Tbk | 3748.83 Billion IDR | 97.929% |